(Q37186658)

18 August 2017

1 reference

title

Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly (English)

1 reference

18 August 2017

0 references

Brian Draper

1

1 reference

18 August 2017

Karen Berman

series ordinal

2

1 reference

18 August 2017

publication date

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

25

1 reference

18 August 2017

issue

6

1 reference

18 August 2017

page(s)

501-519

1 reference

Falls among frail older people in residential care

18 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002512-200825060-00004

Selective serotonin-reuptake inhibitor antidepressants increase the risk of falls and hip fractures in elderly people by inhibiting cardiovascular ion channels

21 January 2018

1 reference

12 December 2020

Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England

1 reference

12 December 2020

Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting

1 reference

12 December 2020

Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction

1 reference

12 December 2020

Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture

1 reference

12 December 2020

CYP2D6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants-a pilot study

1 reference

12 December 2020

SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.

1 reference

12 December 2020

Antidepressant drug use and suicide prevention

1 reference

12 December 2020

Influence of histamine and serotonin antagonists on the growth of xenografted human colorectal tumors.

1 reference

12 December 2020

Pharmacological treatment for unipolar psychotic depression: Systematic review and meta-analysis

1 reference

12 December 2020

Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance

1 reference

12 December 2020

Movement disorders associated with the serotonin selective reuptake inhibitors

1 reference

12 December 2020

Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials

1 reference

12 December 2020

Does increasing dose improve efficacy in patients with poor antidepressant response: a review

1 reference

12 December 2020

Antidepressants for depressed elderly

1 reference

12 December 2020

Does fluoxetine exacerbate Parkinson's disease?

1 reference

12 December 2020

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

1 reference

12 December 2020

Suicide prevention – a medical breakthrough?

1 reference

12 December 2020

Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study

1 reference

12 December 2020

Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis

1 reference

12 December 2020

The antidepressant effects of 5-HT uptake inhibitors.

1 reference

12 December 2020

Postprandial systolic blood pressure responses of older people in residential care: association with risk of falling

1 reference

12 December 2020

Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin

1 reference

12 December 2020

Effects of nortriptyline and paroxetine on postural sway in depressed elderly patients

1 reference

12 December 2020

The evolution of drug metabolism

1 reference

12 December 2020

A randomized, placebo-controlled trial of paroxetine in nursing home residents with non-major depression

1 reference

12 December 2020

Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms

1 reference

12 December 2020

Retrospective review of selective serotonin reuptake inhibitors and falling in older nursing home residents

1 reference

12 December 2020

Hyponatraemia and selective serotonin re-uptake inhibitors in elderly patients

1 reference

12 December 2020

Severe life-threatening hyponatremia during paroxetine therapy

1 reference

12 December 2020

Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism

1 reference

12 December 2020

Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation.

1 reference

12 December 2020

CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages

1 reference

12 December 2020

Use of antidepressants and risk of colorectal cancer: a nested case-control study

1 reference

12 December 2020

Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs

1 reference

12 December 2020

Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa

1 reference

12 December 2020

Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study.

1 reference

12 December 2020

Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit

1 reference

12 December 2020

Reversal of citalopram-induced junctional bradycardia with intravenous sodium bicarbonate

1 reference

12 December 2020

Delayed recurrent SIADH associated with SSRIs

1 reference

12 December 2020

Late-life depression: rationalizing pharmacological treatment options

1 reference

12 December 2020

Pharmacogenetics of antidepressant medication intolerance

1 reference

12 December 2020

Expanding the black box - depression, antidepressants, and the risk of suicide

1 reference

12 December 2020

Antidepressant studies in Parkinson's disease: a review and meta-analysis

1 reference

12 December 2020

Systematic overview of drug interactions with antidepressant medications

1 reference

12 December 2020

Fluoxetine in medically stable, depressed geriatric patients: effects on weight

1 reference

12 December 2020

Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reports

1 reference

12 December 2020

Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system

1 reference

12 December 2020

A double-blind comparison of citalopram (Lu 10-171) and amitriptyline in depressed patients

1 reference

12 December 2020

Pharmacogenomics and antidepressant drugs

1 reference

12 December 2020

Cytochrome P450 2D6 genotype does not predict SSRI (fluoxetine or paroxetine) induced hyponatraemia

1 reference

12 December 2020

Paroxetine decreases platelet serotonin storage and platelet function in human beings

1 reference

12 December 2020

Selective serotonin reuptake inhibitor-induced urinary incontinence

1 reference

12 December 2020

Sertraline-induced hypoglycemia

1 reference

12 December 2020

Selective serotonin reuptake inhibitors and hyponatraemia: review and proposed mechanisms in the elderly

1 reference

12 December 2020

Antidepressant medication use and breast cancer risk

1 reference

12 December 2020

General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction.

1 reference

12 December 2020

Dysphonia induced by selective serotonin reuptake inhibitors

1 reference

12 December 2020

Selective serotonin reuptake inhibitors and myocardial infarction

1 reference

12 December 2020

Danger of MAOI therapy after fluoxetine withdrawal

1 reference

12 December 2020

Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review.

1 reference

12 December 2020

Effect of depression on stroke morbidity and mortality

1 reference

12 December 2020

A case of paroxetine-induced galactorrhea

1 reference

12 December 2020

Review: tricyclic related drugs, but not classical tricyclics, are a tolerable alternative to SSRIs in older people with depression

1 reference

12 December 2020

A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action

1 reference

12 December 2020

Use of selective serotonin reuptake inhibitors and sleep disturbances in community-dwelling older women

1 reference

12 December 2020

Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system

1 reference

12 December 2020

Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression

1 reference

12 December 2020

A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis

1 reference

12 December 2020

Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial.

1 reference

12 December 2020

Drugs and falls in older people in geriatric care settings

1 reference

12 December 2020

The clinical pharmacokinetics of escitalopram

1 reference

12 December 2020

Late-life depression: a model for medical classification.

1 reference

12 December 2020

Bleeding and selective serotonin reuptake inhibitors in childhood and adolescence

1 reference

12 December 2020

Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients

1 reference

12 December 2020

Cerebral vasoconstriction and stroke after use of serotonergic drugs

1 reference

12 December 2020

Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram

1 reference

12 December 2020

Fluoxetine in elderly patients: is there cause for concern?

1 reference

12 December 2020

Weight outcomes among antidepressant users in nursing facilities

1 reference

12 December 2020

The role of psychological factors in alopecia areata and the impact of the disease on the quality of life.

1 reference

12 December 2020

Adverse events in users of sertraline: results from an observational study in psychiatric practice in The Netherlands

1 reference

12 December 2020

Memory loss in a patient treated with fluoxetine

1 reference

12 December 2020

Tolerability of paroxetine in Parkinson's disease: A prospective study

1 reference

12 December 2020

Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose

1 reference

12 December 2020

Antidepressant-associated mania and psychosis resulting in psychiatric admissions

1 reference

12 December 2020

Nocturia, depression and antidepressant medication

1 reference

12 December 2020

No evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline

1 reference

12 December 2020

Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP.

1 reference

12 December 2020

Hair loss in psychopharmacology

1 reference

12 December 2020

Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study

1 reference

12 December 2020

Paroxetine and galactorrhea

1 reference

12 December 2020

Rhabdomyolysis: an evaluation of 475 hospitalized patients.

1 reference

12 December 2020

Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine

1 reference

12 December 2020

Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment

1 reference

12 December 2020

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment

1 reference

12 December 2020

Cytochrome P450 2D6 and antidepressant toxicity and response: what is the evidence?

1 reference

12 December 2020

Selective serotonin reuptake inhibitors in older patients. A tolerability perspective

1 reference

12 December 2020

Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysis.

1 reference

12 December 2020

Outpatient medications and hip fractures in the US: a national veterans study

1 reference

12 December 2020

Effects of serotonin on cerebral circulation after middle cerebral artery occlusion

1 reference

12 December 2020

Effect of selective serotonin reuptake inhibitors on the risk of fracture

1 reference

12 December 2020

Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults

1 reference

12 December 2020

Depression treatment in a sample of 1,801 depressed older adults in primary care

1 reference

12 December 2020

Central nervous system active medications and risk for fractures in older women

1 reference

12 December 2020

Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs).

1 reference

12 December 2020

Paroxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling

1 reference

12 December 2020

Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people.

1 reference

12 December 2020

Effect of nortriptyline and paroxetine on CYP2D6 activity in depressed elderly patients

1 reference

12 December 2020

Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate

1 reference

12 December 2020

The Serotonin Syndrome

1 reference

12 December 2020

Antidepressant medication use and breast cancer risk: a case-control study

1 reference

12 December 2020

The risk of suicide with selective serotonin reuptake inhibitors in the elderly

1 reference

12 December 2020

Paroxetine and fluoxetine effects on mood and cognitive functions in depressed nondemented elderly patients.

1 reference

12 December 2020

A randomized, controlled trial of the effectiveness of cognitive-behavioral therapy and sertraline versus a waitlist control group for anxiety disorders in older adults

1 reference

12 December 2020

Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview

1 reference

12 December 2020

Cisapride for the treatment of nausea produced by selective serotonin reuptake inhibitors

1 reference

12 December 2020

Drug interactions of clinical significance with selective serotonin reuptake inhibitors

1 reference

12 December 2020

Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction

1 reference

12 December 2020

Adverse Drug Events in Ambulatory Care

1 reference

12 December 2020

Antidepressant use and breast cancer risk

1 reference

12 December 2020

Newer antidepressants: evaluation of fatal toxicity index and interaction with alcohol based on Finnish postmortem data

1 reference

12 December 2020

Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial

1 reference

12 December 2020

Differential effectiveness of newer and older antidepressants appears mediated by an age effect on the phenotypic expression of depression

1 reference

12 December 2020

Suicide and self-harm following prescription of SSRIs and other antidepressants: confounding by indication.

1 reference

12 December 2020

Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study

1 reference

12 December 2020

Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice

1 reference

12 December 2020

Escitalopram in clinical practice: results of an open-label trial in a naturalistic setting

1 reference

12 December 2020

Paroxetine in Parkinson's disease: effects on motor and depressive symptoms

1 reference

12 December 2020

Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis

1 reference

12 December 2020

Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients

1 reference

12 December 2020

Discontinuation of use and switching of antidepressants: influence of patient-physician communication

1 reference

12 December 2020

Paroxetine-induced conversion of cytochrome P450 2D6 phenotype and occurence of adverse effects

1 reference

12 December 2020

Antidepressant prescribing and suicide: Associations attribute possible causality inappropriately

1 reference

12 December 2020

Antidepressants, warfarin, and the risk of hemorrhage

1 reference

12 December 2020

Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?

1 reference

12 December 2020

Paroxetine, a cytochrome P450 2D6 inhibitor, diminishes the stereoselective O-demethylation and reduces the hypoalgesic effect of tramadol

1 reference

12 December 2020

Recent advances in geriatric psychopharmacology

1 reference

12 December 2020

Antidepressant use and the risk of breast cancer: a non-association

1 reference

12 December 2020

Length of therapy with selective serotonin reuptake inhibitors and tricyclic antidepressants in Australia

1 reference

12 December 2020

Serotonergic antidepressants and urinary incontinence

1 reference

12 December 2020

Galactorrhea after paroxetine treatment

1 reference

12 December 2020

Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction

1 reference

12 December 2020

Antidepressant drug use in primary care: a record linkage study in Tayside, Scotland

1 reference

12 December 2020

Serotonergic innervation of the cerebral vasculature: relevance to migraine and ischaemia

1 reference

12 December 2020

Suicide, depression, and antidepressants

1 reference

12 December 2020

Risk of Breast Cancer According to Use of Antidepressants, Phenothizaines, and Anthistamines

1 reference

12 December 2020

Risk of syncope in the elderly and consumption of drugs: a case-control study

1 reference

12 December 2020

Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors

1 reference

12 December 2020

10.2165/00002512-200825060-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

18 August 2017

1021669688

0 references

1 reference